The Role of Type i IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?

46Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The important role of interferons (IFNs) in antiviral innate immune defense is well established. Although recombinant IFN-α was approved for cancer and chronic viral infection treatment by regulatory agencies in many countries starting in 1986, no IFNs are approved for treatment of influenza A virus (IAV) infection. This is partially due to the complex effects of IFNs in acute influenza infection. IAV attacks the human respiratory system and causes significant morbidity and mortality globally. During influenza infection, depending on the strain of IAV and the individual host, type I IFNs can have protective antiviral effects or can contribute to immunopathology. In the context of virus infection, the immune system has complicated mechanisms regulating the expression and effects of type I IFN to maximize the antiviral response by both activating and enhancing beneficial innate cell function, while limiting immunopathological responses that lead to exaggerated tissue damage. In this review, we summarize the complicated, but important, role of type I IFNs in influenza infections. This includes both protective and harmful effects of these important cytokines during infection.

Cite

CITATION STYLE

APA

Wu, W., & Metcalf, J. P. (2020, November 1). The Role of Type i IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains? Journal of Innate Immunity. S. Karger AG. https://doi.org/10.1159/000508379

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free